Description: Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is based in Visakhapatnam, India.
Home Page: krebsbiochem.com
Kothapalli Village
Visakhapatnam,
531031
India
Phone:
91 91 2114 4984
Officers
| Name | Title |
|---|---|
| Mr. Jitendra Rameshchandra Shah | MD, CEO & Director |
| Mr. Ritesh Jain | Chief Financial Officer |
| Mr. Rakesh R. Kalbate | Company Secretary & Compliance Officer |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 4.6675 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 191 |